ArticleNature communications2020

Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma.

Eugenia Zah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.